These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9243500)

  • 1. The role of the Src homology domains in morphological transformation by v-src.
    Tian M; Martin GS
    Mol Biol Cell; 1997 Jul; 8(7):1183-93. PubMed ID: 9243500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M; Howell BW; Broome MA; Cooper JA
    J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation.
    Catling AD; Fincham VJ; Frame MC; Haefner B; Wyke JA
    J Virol; 1994 Jul; 68(7):4392-9. PubMed ID: 8207813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pp60v-src transformation of rat cells but not chicken cells strongly correlates with low-affinity phosphopeptide binding by the SH2 domain.
    Verderame MF
    Mol Biol Cell; 1997 May; 8(5):843-54. PubMed ID: 9168470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src.
    Seidel-Dugan C; Meyer BE; Thomas SM; Brugge JS
    Mol Cell Biol; 1992 Apr; 12(4):1835-45. PubMed ID: 1549129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of connexin 43 by v-Src is mediated by SH2 and SH3 domain interactions.
    Kanemitsu MY; Loo LW; Simon S; Lau AF; Eckhart W
    J Biol Chem; 1997 Sep; 272(36):22824-31. PubMed ID: 9278444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
    Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
    J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.
    Matsuda M; Reichman CT; Hanafusa H
    J Virol; 1992 Jan; 66(1):115-21. PubMed ID: 1370084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processive phosphorylation of p130Cas by Src depends on SH3-polyproline interactions.
    Pellicena P; Miller WT
    J Biol Chem; 2001 Jul; 276(30):28190-6. PubMed ID: 11389136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integrity of the SH3 binding motif of AFAP-110 is required to facilitate tyrosine phosphorylation by, and stable complex formation with, Src.
    Guappone AC; Flynn DC
    Mol Cell Biochem; 1997 Oct; 175(1-2):243-52. PubMed ID: 9350057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host range mutants of v-src: alterations in kinase activity and substrate interactions.
    Liebl EC; England LJ; DeClue JE; Martin GS
    J Virol; 1992 Jul; 66(7):4315-24. PubMed ID: 1534851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src.
    Hirai H; Varmus HE
    Mol Cell Biol; 1990 Apr; 10(4):1307-18. PubMed ID: 2108315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophosphorylation is required for high kinase activity and efficient transformation ability of proteins encoded by host range alleles of v-src.
    Woods KM; Verderame MF
    J Virol; 1994 Nov; 68(11):7267-74. PubMed ID: 7933110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate.
    Flynn DC; Leu TH; Reynolds AB; Parsons JT
    Mol Cell Biol; 1993 Dec; 13(12):7892-900. PubMed ID: 8247004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain.
    Xu B; Miller WT
    Mol Cell Biochem; 1996 May; 158(1):57-63. PubMed ID: 8791285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.
    Liu X; Marengere LE; Koch CA; Pawson T
    Mol Cell Biol; 1993 Sep; 13(9):5225-32. PubMed ID: 7689147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes.
    Lynch BA; Minor C; Loiacono KA; van Schravendijk MR; Ram MK; Sundaramoorthi R; Adams SE; Phillips T; Holt D; Rickles RJ; MacNeil IA
    Anal Biochem; 1999 Nov; 275(1):62-73. PubMed ID: 10542110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.